newsfilter
← Latest News
Business Wire·

Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended June 30, 2025 and provided